Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker (Neurogenetics (2006) 7 (223-229) DOI: 10.1007/s10048-006-0048-y);Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker

Neurogenetics

Volumn 7, Issue 4, 2006, Pages 223-229

  Juyal, Ramesh C ^a   Das, Mitashree ^a   Punia, Sohan ^b   Behari, Madhuri ^c   Nainwal, Geetika ^a   Singh, Sumit ^c   Swaminath, Pazhayannur V ^d   Govindappa, Shyla T ^d   Jayaram, Sachi ^d   Muthane, Uday B ^d   Thelma, B K ^b  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b UNIVERSITY OF DELHI   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Dopamine receptor; Dopamine transporter; Indian population; Parkinson's disease; Single nucleotide polymorphism

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DUPLICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR GENE; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 33750077596     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-007-0108-y     Document Type: Erratum

References (43)

1. de Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S, Manubens-Bertran JM, Alperovitch A, Rocca WA (1997) Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 62(1):10-15
2. Huang Y, Cheung L, Rowe D, Halliday G (2004) Genetic contributions to Parkinson's disease. Brain Res Brain Res Rev 46(1):44-70
3. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (5646):819-822
4. Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276(5321):2045-2047
5. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605-608
6. Leroy E, Boyer R, Auburger G et al (1998) The ubiquitin pathway in Parkinson's disease. Nature 395(6701):451-452
7. Bonifati V, Rizzu P, van Baren MJ et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299(5604):256-259
8. Valente EM, Abou-Sleiman PM, Caputo V et al (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304(5674):1158-1160
9. Paisan-Ruiz C, Jain S, Evans EW et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44(4):595-600
10. Snyder SH, D'Amato RJ (1986) MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease The 1985 George C Cotzias lecture. Neurology 36(2):250-258
11. Williams A, Waring R (1993) The MPTP tale: pathway to prevention of Parkinson's disease? Br J Hosp Med 49(10):716-719
12. Prasad KN, Cole WC, Kumar B (1999) Multiple antioxidants in the prevention and treatment of Parkinson's disease. J Am Coll Nutr 18(5):413-423
13. Ischiropoulos H, Beckman JS (2003) Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111(2):163-169
14. Kidd PM (2000) Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern Med Rev 5(6):502-529
15. Schapira AH, Gu M, Taanman JW, Tabrizi SJ, Seaton T, Cleeter M, Cooper JM (1998) Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann Neurol 44(3 Suppl 1):S89-S98
16. Kosel S, Hofhaus G, Maassen A, Vieregge P, Graeber MB (1999) Role of mitochondria in Parkinson disease. Biol Chem 380(7-8):865-870
17. Rubinstein M, Phillips TJ, Bunzow JR et al (1997) Mice lacking dopamine D4 receptors are supersensitive to ethanol cocaine and methamphetamine. Cell 90(6):991-1001
18. Oliveri RL, Annesi G, Zappia M et al (2000) The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease. Mov Disord (1):127-131
19. Tan EK, Tan Y, Chai A et al (2003) Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease. Mov Disord 18(5):593-595
20. Ricketts MH, Hamer RM, Manowitz P, Feng F, Sage JI, Di Paola R, Menza MA (1998) Association of long variants of the dopamine D4 receptor exon 3 repeat polymorphism with Parkinson's disease. Clin Genet 54(1):33-38
21. Wan DC, Law LK, Ip DT, Cheung WT, Ho WK, Tsim KW, Kay R, Woo J, Pang CP (1999) Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a Chinese population. Mov Disord 14(2):225-229
22. Grondin R, Doan VD, Gregoire L, Bedard PJ (1999) D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys. Neurology 52(4):771-776
23. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (2001) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 (6289):146-151
24. Zappia M, Annesi G, Quattrone A (2002) Association study of dopamine D2 D3 receptor gene polymorphisms with motor fluctuations in PD. Neurology 58(5):837
25. Wang J, Zhao C, Chen B, Liu ZL (2004) Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease. Neurosci Lett 355(3):193-196
26. Srivastava V, Varma PG, Prasad S, Semwal P, Nimgaonkar VL, Lerer B, Deshpande SN, Thelma BK (2006) Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: ÉV. Role of dopaminergic pathway gene polymorphisms. Pharmacogenet Genomics 16(2):111-117
27. Accili D, Fishburn CS, Drago J et al (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93(5):1945-1949
28. Mercier G, Turpin JC, Lucotte G (1999) Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found. J Neurol 246(1):45-47
29. Lin JJ, Yueh KC, Chang DC, Chang CY, Yeh YH, Lin SZ (2003) The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male but not to female patients. J Neurol Sci 209(1-2):87-92
30. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181-184
31. Sato M, Soma M, Nakayama T, Kanmatsuse K (2000) Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 36(2):183-186
32. Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M (1993) A structural polymorphism of human dopamine D2 receptor D2(Ser311→Cys). Biochem Biophys Res Commun 196(3):1369-1375
33. Grandy DK, Zhang Y, Civelli O (1993) PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 2(12):2197
34. Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA, Potkin SG, Macciardi F, Kennedy JL (1999) Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology 21(1):17-27
35. Seaman MI, Fisher JB, Chang F, Kidd KK (1999) Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4). Am J Med Genet 88(6):705-709
36. Okuyama Y, Ishiguro H, Toru M, Arinami T (1999) A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 258(2):292-295
37. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O (2001) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350(6319):610-614
38. Sano A, Kondoh K, Kakimoto Y, Kondo I (1993) A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 91(4):405-406
39. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
40. Stephens M, Donnelly P (2001) Comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73(6):1162-1169
41. Cavalli-Sforza LL, Menozzi P, Piazza A (1994) The history and geography of human genes. Princeton University Press, Princeton, NJ, pp 19-20, 101-102, 238-242
42. Passarino G, Semino O, Bernini LF, Santachiara-Benerecetti AS (1996) Pre-Caucasoid and Caucasoid genetic features of the Indian population, revealed by mtDNA polymorphisms. Am J Hum Genet 59(4):927-934
43. D'Souza UM, Russ C, Tahir E, Mill J, McGuffin P, Asherson PJ, Craig IW (2004) Functional effects of a tandem duplication polymorphism in the 5′flanking region of the DRD4 gene. Biol Psychiatry 56(9):691-697